Skip to content

Evaluation of the integration of artificial intelligence in quality-assured breast diagnostics in Schleswig-Holstein

Evaluation of the integration of artificial intelligence in quality-assured breast diagnostics in Schleswig-Holstein - QuaMaDi-KI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037604
Enrollment
128000
Registered
2026-05-04
Start date
2026-05-28
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50

Interventions

Group 1: In gynaecological practices with such AI systems installed: Initial diagnosis with aid of AI, possibly followed by human second opinion Group 2: In gynaecological practices without such AI sy

Sponsors

Kassenärztliche Vereinigung Schleswig-Holstein
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Participation in QuaMaDi • Performing a mammogram as part of QuaMaDi

Exclusion criteria

Exclusion criteria: • Waiver of mammography in favour of other imaging procedures (e.g. sonography) within the framework of QuaMaDi • Age under 18 years

Design outcomes

Primary

MeasureTime frame
• Breast Cancer Detection Rate, calculated using the number of positive, histologically confirmed biopsy results within QuaMaDi divided by the number of women examined • Recall Rate

Secondary

MeasureTime frame
• Number of other diagnosis tests prior to a biopsy (overall and in categories (ultrasound, MRI, further mammography, other if specified) for women getting a recall • Number of biopsies among all women getting recalled • The number of histologically positive biopsies among all women getting recalled (PPV I) • The number of histologically positive biopsies among all biopsies (PPV II) • If possible: The amount of time needed for diagnosis of i) Mammograms without a following histologically positive biopsy ii) Mammograms with AI information „not suspicious/normal“ and iii) Mammograms with a following histologically positive biopsy

Countries

Germany

Contacts

Public ContactHannah Baltus

Universität zu Lübeck; Institut für Sozialmedizin und Epidemiologie

hannah.baltus@uksh.de+49 451 500 51272

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026